These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypolipidemic effect of clofibrate and fatty acid oxidation in peroxisomes. Nutr Rev; 1977 Apr; 35(4):74-5. PubMed ID: 323754 [No Abstract] [Full Text] [Related]
4. [Peroxisomes and hypolipidemic agents ]. Heller F; Pourbaix S Sem Hop; 1982 Jul; 58(28-29):1712-7. PubMed ID: 6289453 [TBL] [Abstract][Full Text] [Related]
5. On the role of peroxisomes in the metabolism of lipids--evidence from studies on mammalian tissues in vivo. Masters C; Crane D Mol Cell Biochem; 1984 Nov; 65(1):23-35. PubMed ID: 6521729 [TBL] [Abstract][Full Text] [Related]
6. Lipid composition of liver peroxisomes isolated from untreated and clofibrate-treated mice and rats. Kyrklund T; Meijer J Comp Biochem Physiol B Biochem Mol Biol; 1994 Dec; 109(4):665-73. PubMed ID: 7881828 [TBL] [Abstract][Full Text] [Related]
7. Reduction of all-trans-retinal in the mouse liver peroxisome fraction by the short-chain dehydrogenase/reductase RRD: induction by the PPAR alpha ligand clofibrate. Lei Z; Chen W; Zhang M; Napoli JL Biochemistry; 2003 Apr; 42(14):4190-6. PubMed ID: 12680773 [TBL] [Abstract][Full Text] [Related]
8. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat. Staels B; Van Tol A; Fruchart JC; Auwerx J Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657 [TBL] [Abstract][Full Text] [Related]
9. Peroxisomes in lipid metabolism. Seedorf U J Cell Biochem Suppl; 1998; 30-31():158-67. PubMed ID: 9893267 [TBL] [Abstract][Full Text] [Related]
11. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure. Korczyńska J; Stelmańska E; Nieweglowski T; Szołkiewicz M; Rutkowski B; Swierczyński J Pol J Pharmacol; 2000; 52(4):291-7. PubMed ID: 11345485 [TBL] [Abstract][Full Text] [Related]
12. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. Waxman DJ J Endocrinol; 1996 Sep; 150 Suppl():S129-47. PubMed ID: 8943797 [TBL] [Abstract][Full Text] [Related]
13. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Wang G; Shen H; Rajaraman G; Roberts MS; Gong Y; Jiang P; Burczynski F Eur J Pharmacol; 2007 Mar; 560(1):61-8. PubMed ID: 17292345 [TBL] [Abstract][Full Text] [Related]
14. Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs. Reddy JK J Histochem Cytochem; 1973 Nov; 21(11):967-71. PubMed ID: 4587529 [No Abstract] [Full Text] [Related]
15. Effects of clofibrate treatment and of starvation on peroxisomes, mitochondria, and lipid droplets in mouse hepatocytes: a morphometric study. Meijer J; Afzelius BA J Ultrastruct Mol Struct Res; 1989 Apr; 102(1):87-94. PubMed ID: 2621378 [TBL] [Abstract][Full Text] [Related]
19. Role of hypolipidemic drug clofibrate in altering iron regulatory proteins IRP1 and IRP2 activities and hepatic iron metabolism in rats fed a low-iron diet. Huang HL; Shaw NS Toxicol Appl Pharmacol; 2002 Apr; 180(2):118-28. PubMed ID: 11969379 [TBL] [Abstract][Full Text] [Related]
20. [Proliferation inhibition and lipid accumulation in cell cultures with clofibrinic acid (Regadrin)]. Jakob W; Mauersberger B; Krieg K; Minenko A Pharmazie; 1977 Dec; 32(12):798-800. PubMed ID: 613323 [No Abstract] [Full Text] [Related] [Next] [New Search]